| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/1997 | WO1996040258A3 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 01/23/1997 | WO1996040255A3 Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist |
| 01/23/1997 | WO1996040253A3 Rna photocleavage using texaphyrins |
| 01/23/1997 | WO1996040250A3 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 01/23/1997 | WO1996040168A3 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 01/23/1997 | WO1996040113A3 Phosphatase inhibitors |
| 01/23/1997 | WO1996028151A3 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/23/1997 | DE19618778A1 Use of androstanone and androstenone derivs. for treating psoriasis |
| 01/23/1997 | DE19526864A1 Hormonpflaster Hormone patches |
| 01/23/1997 | DE19525999A1 Improved treatment for early infant epilepsy |
| 01/23/1997 | CA2587000A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | CA2226310A1 New pyrido-thiopyranoindazoles with anti-tumor activity |
| 01/23/1997 | CA2226262A1 Production of .beta.-glucan-mannan preparations by autolysis of cells under certain ph, temperature and time conditions |
| 01/23/1997 | CA2226258A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | CA2226008A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | CA2225674A1 Therapeutic effervescent compositions |
| 01/23/1997 | CA2225668A1 Use of stat 6 sh2 domain specific compounds to treat allergic reactions |
| 01/23/1997 | CA2225666A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | CA2225627A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 01/23/1997 | CA2225616A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | CA2225391A1 Compounds and pharmaceutical compositions containing them |
| 01/23/1997 | CA2225282A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
| 01/23/1997 | CA2224715A1 Macrolides |
| 01/23/1997 | CA2224451A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/23/1997 | CA2222844A1 Water activable adhesive matrix containing amethocaine |
| 01/23/1997 | CA2222725A1 Therapeutic agents |
| 01/23/1997 | CA2198729A1 A novel human map kinase homolog |
| 01/23/1997 | CA2198085A1 Inactivation of pathogens using hydroxymethylamines |
| 01/23/1997 | CA2197568A1 Uricosuric agents |
| 01/22/1997 | EP0754693A2 Novel aminophenylphosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754682A1 Aminostilbazole derivative and medicine |
| 01/22/1997 | EP0754680A1 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic as well as medicaments containing them |
| 01/22/1997 | EP0754678A2 Improvement of physiological tolerance of pharmaceutical active beta-amino acids |
| 01/22/1997 | EP0754461A2 A preservation solution of blood platelets |
| 01/22/1997 | EP0754460A1 Antiinflammatory agents |
| 01/22/1997 | EP0754459A1 Composition containing glycans corresponding to transferrin glycans as an active principle for the induction of immune tolerance against antigens |
| 01/22/1997 | EP0754458A1 Antiallergic composition comprising a phosphoric diester compound |
| 01/22/1997 | EP0754457A1 Antiobestic agent |
| 01/22/1997 | EP0754456A2 Topical application of ST1435 as a contraceptive agent |
| 01/22/1997 | EP0754455A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases |
| 01/22/1997 | EP0754454A1 Cholinesterase activator |
| 01/22/1997 | EP0754453A1 Local anesthetics for topical treatment of headache |
| 01/22/1997 | EP0754450A1 Vitamin-mineral treatment methods and compositions |
| 01/22/1997 | EP0754447A1 Skin-cosmetic composition |
| 01/22/1997 | EP0754445A2 Photostable cosmetic light screening compositions |
| 01/22/1997 | EP0754302A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 01/22/1997 | EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754223A1 Non-pathogenic strains of hiv-1 |
| 01/22/1997 | EP0754190A1 An equilin double bond isomer from the acid isomerization of equilin |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754188A1 Oligonucleotides with anti-cytomegalovirus activity |
| 01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
| 01/22/1997 | EP0754184A1 Cephalosporin antibiotics |
| 01/22/1997 | EP0754183A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug |
| 01/22/1997 | EP0754180A1 Anti-helicobacter ester and carbamate derivatives of azolones |
| 01/22/1997 | EP0754176A1 Novel carbamates and ureas as modifiers of multi-drug resistance |
| 01/22/1997 | EP0754173A1 Method for purifying diacetyl rhein |
| 01/22/1997 | EP0754069A1 Methods for treating pulmonary vasoconstriction and asthma |
| 01/22/1997 | EP0754061A1 New oral pharmaceutical dosage form |
| 01/22/1997 | EP0754060A1 NEW COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC |
| 01/22/1997 | EP0754053A1 Novel hemostatic composition |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
| 01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
| 01/22/1997 | EP0754047A1 Injectable solutions of dirithromycin |
| 01/22/1997 | EP0754046A1 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure |
| 01/22/1997 | EP0754045A1 Halofantrine free base for the treatment of malaria and compositions |
| 01/22/1997 | EP0754044A1 Novel iron chelator and inhibitor of iron-mediated oxidation |
| 01/22/1997 | EP0754043A1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 01/22/1997 | EP0754042A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754040A1 Rapamycin derivatives |
| 01/22/1997 | EP0754039A1 Methods of using iron chelating compounds to reduce free radical damage in mammals |
| 01/22/1997 | EP0754038A1 Use of benzylidene-malononitrile derivates for the treatment of leukemia |
| 01/22/1997 | EP0754037A1 Methods of administering n-substituted benzamides or phenothiazines |
| 01/22/1997 | EP0754036A1 Permanently ionic derivatives of steroid hormones and their antagonists |
| 01/22/1997 | EP0754035A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
| 01/22/1997 | EP0754033A1 Heterofunctional, mucoadhesive dosage form |
| 01/22/1997 | EP0754030A1 Method for stabilizing duocarmycin derivatives |
| 01/22/1997 | EP0754024A1 Inhibition of hair growth |
| 01/22/1997 | EP0699187B1 Beta,beta-dimethyl-4-piperidineethanamine derivatives as inhibitors of the cholesterol biosynthesis |
| 01/22/1997 | EP0698024B1 [1,2,4]TRIAZOLO [4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE |
| 01/22/1997 | EP0687177B1 Use of lamotrigine for treating aids-related neural disorders |
| 01/22/1997 | EP0677048B1 Cyclic sulfone containing retroviral protease inhibitors |
| 01/22/1997 | EP0669916B1 Novel method for preparing taxane derivatives, novel derivatives thus obtained and compositions containing them |
| 01/22/1997 | EP0659079B1 Transdermal therapeutic system with pentylene tetrazol as active substance |
| 01/22/1997 | EP0656898B1 Pyridopyrimidinone antianginal agents |
| 01/22/1997 | EP0656774B1 Cosmetic and dermatological sunscreen compositions containing thiols and/or thiol derivates |
| 01/22/1997 | EP0644763B1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs |
| 01/22/1997 | EP0642338B1 USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE |
| 01/22/1997 | EP0615450B1 Dimeticon pastilles |
| 01/22/1997 | EP0601002B1 Bicyclic sulphones, process for producing the same and medicaments containing the same |
| 01/22/1997 | EP0593656B1 Novel compositions based on taxane class derivatives |
| 01/22/1997 | EP0593419B1 Inhibitors for glycosaminosyl transferase-v |
| 01/22/1997 | EP0559695B1 New pyridine derivatives, methods of preparing them and their use as drugs |
| 01/22/1997 | EP0555481B1 Tri(c1-c6 alkoxy)benzene derivative |